Gavin Mathis (@gavinmathis) 's Twitter Profile
Gavin Mathis

@gavinmathis

Partner at @PrimeMoversLab | Emerging tech and breakthrough science startups

ID: 74572767

linkhttps://www.primemoverslab.com/ calendar_today15-09-2009 22:16:43

1,1K Tweet

257 Followers

539 Following

Boom Supersonic (@boomaero) 's Twitter Profile Photo

“We didn’t invent anything new. This is an incredibly pragmatic approach to supersonic flight.” Founder and CEO Blake Scholl 🛫 on CNBC earlier today, speaking to Boom’s progress toward delivering supersonic flight by 2029. This as XB-1 readies for its third test flight in Mojave, CA.

Gavin Mathis (@gavinmathis) 's Twitter Profile Photo

As a former journalist, I'm excited that Prime Movers Lab is backing ProRata.ai & Bill Gross. Publishers & creators should be fairly compensated by generative #AI providers. Media outlets failed to understand the repercussions of the Media 2.0 wave and that can't happen again.

Gavin Mathis (@gavinmathis) 's Twitter Profile Photo

Completely agree. It makes far more sense to be investing in #hypersonic drones that can deliver payloads at a fraction of the cost of manned F-35s. The future of warfare will depend on volume, speed, and autonomy.

Gavin Mathis (@gavinmathis) 's Twitter Profile Photo

The Chinese fusion reactor images that emerged this week should be a far more concerning "Sputnik moment" for Americans than Deepseek. Energy is the engine of global political and economic change and (unfortunately) conflict. I wish members of Congress were making as much

Gavin Mathis (@gavinmathis) 's Twitter Profile Photo

Wait until they discover that Jurassic Park used CGI to make those dinosaurs rather than use real ones. Why is there such an irrational fear of AI? Regardless, people should see The Brutalist. It's the best American film since There Will Be Blood. variety.com/2025/artisans/…

Gavin Mathis (@gavinmathis) 's Twitter Profile Photo

I had a fascinating conversation with LyGenesis CEO Michael Hufford on the Prime Movers podcast this week. Check out the full conversation below about the company's regenerative cell therapy for patients with end-stage liver disease.

Gavin Mathis (@gavinmathis) 's Twitter Profile Photo

Excited that my home state is expanding its right to try legislation. Innovated regulatory approaches like this are needed to extend human lifespans and achieve medical autonomy. I hope Montana becomes a test bed for innovative breakthroughs. bit.ly/3GVTgkQ

Gavin Mathis (@gavinmathis) 's Twitter Profile Photo

I hope Tapper's book is a flop. The slightest amount of reporting a year ago would have uncovered the extent of Biden's health issues. Instead, Tapper shamed people who did the job that he was supposed to do. Now, he is trying to make a buck and pretend that he did any reporting

AbbVie (@abbvie) 's Twitter Profile Photo

JUST IN: We’ve signed a definitive agreement to acquire Gilgamesh Pharma lead investigational therapy. This agreement demonstrates our commitment to pursuing novel treatment approaches and transforming patient care in #psychiatry. Learn more: abbv.ie/adg